Updates in Pediatric Influenza: When and How to Deploy the Antiviral Arsenal
Released On
November 10, 2022
Expires On
November 10, 2023
Media Type
Internet
Completion Time
90 minutes
Specialty
Emergency Medicine, Infectious Disease, Pediatrics, Primary Care
Topic(s)
Asthma, Pediatrics, Respiratory
Scroll to the Bottom of this Information to Begin this Course
This recorded symposium is not sponsored, endorsed, or accredited by the American Academy of Pediatrics.
This activity is provided by Paradigm Medical Communications, LLC.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Physician Assistants — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Nurses — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity has been designed to meet the educational needs of pediatricians. It may also benefit family medicine practitioners, internal medicine specialists, infectious disease specialists, and other clinicians involved in the care of patients with influenza.
Program Overview
Experts predict that a resurgence of influenza is not a matter of if, but when, as COVID-19 mitigation measures that also suppressed seasonal influenza caseloads lift, and the continued threat of COVID-19 complicates influenza diagnosis and treatment, particularly in children. Because the success of influenza antiviral treatment hinges on early initiation, accurate diagnosis is essential to improving influenza care and outcomes.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Distinguish presentations of pediatric influenza from other respiratory viral diseases
- Compare clinical trial data for oral influenza antiviral agents for use in children
- Develop individualized influenza treatment and prophylaxis plans for children with, or at risk for, influenza based on current data and unique agent characteristics
Faculty
Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Attending, Division of Infectious Diseases
Medical Director, International Patient and Destination Services Program
Ann and Robert H. Lurie Children’s Hospital of Chicago
Chicago, IL
Flor M. Munoz, MD, MSc
Associate Professor of Pediatrics, Molecular Virology and Microbiology
Baylor College of Medicine
Medical Director, Transplant Infectious Diseases
Texas Children’s Hospital
Houston, TX
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
This recorded symposium is not sponsored, endorsed, or accredited by the American Academy of Pediatrics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Relevant Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.
All relevant relationships are identified and mitigated according to Paradigm policy prior to individuals assuming their roles and are disclosed prior to learners’ engagement in the activity. Paradigm is committed to providing learners with high-quality accredited continuing education that promotes improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The content of this activity was independently reviewed to ensure that it is fair and balanced, scientifically rigorous, evidence based, and aligned with the public interest. All relevant relationships have been mitigated.
- Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
-
- Advisor: GlaxoSmithKline; Merck & Co, Inc; Moderna, Inc; Pfizer Inc; Sanofi
- Research Funding: GlaxoSmithKline
- Flor M. Munoz, MD, MSc
-
- Consultant: AstraZeneca; GlaxoSmithKline; Novavax
- Research Funding: Gilead Sciences, Inc.; Pfizer Inc
- Other: DSMB member
Paradigm Medical Communications, LLC staff members have no relevant financial relationships with ineligible companies to disclose.
Independent peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Instructions for Participation and Credit
To receive a certificate of participation, participants must:
- Follow instructions to register or log in with your professional information and complete the preassessment
- View the online activity in its entirety
- Complete and submit the online postassessment and evaluation. You must answer 70% of the postassessment questions correctly to earn credit. You will have unlimited opportunities to successfully complete the postassessment
A certificate of participation will be available for download/printing immediately following your successful completion of the postassessment and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.
There are no fees for participating in this activity.
Course Viewing Requirements
This accredited CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader
Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Information
If you have any questions or comments, please email us at contactus@paradigmmc.com.
© 2022 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.